TNFα induces NFκB/p50 in association with the growth and morphogenesis of normal and transformed rat mammary epithelial cells

Journal of Cellular Physiology

Volumn 188, Issue 1, 2001, Pages 120-131

  Varela, Linda M ^a   Stangle Castor, Nannette C ^a   Shoemaker, Suzanne F ^a   Shea Eaton, Wendy K ^a   Ip, Margot M ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METHYLNITROSOUREA; PROTEIN DERIVATIVE; PROTEIN P105; PROTEIN P50; SYNAPTOTAGMIN; TUMOR NECROSIS FACTOR ALPHA; DNA BINDING PROTEIN;

ANIMAL CELL; ARTICLE; BREAST EPITHELIUM; CARCINOGENESIS; CELL GROWTH; CELL MATURATION; CELL TRANSFORMATION; CONTROLLED STUDY; DNA PROTEIN COMPLEX; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; ADENOCARCINOMA; ANIMAL; CELL CULTURE; CYTOLOGY; CYTOPLASM; DRUG EFFECT; EPITHELIUM CELL; EXPERIMENTAL NEOPLASM; FEMALE; HELA CELL; HUMAN; IMMUNOBLOTTING; METABOLISM; MORPHOGENESIS; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; UDDER;

ADENOCARCINOMA; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; DNA-BINDING PROTEINS; EPITHELIAL CELLS; FEMALE; HELA CELLS; HUMANS; IMMUNOBLOTTING; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MORPHOGENESIS; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; ORGANOIDS; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034744035     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.1103     Document Type: Article

References (64)

1. Bargou RC, Leng C, Krappmann D, Emmerich F, Mapara MY, Bommert K, Royer HD, Scheidereit C, Dorken B. 2000. High-level nuclear Nf-κB and Oct-2 is a common feature of cultured Hodgkin/ Reed-Sternberg cells. Blood 87:4340-4347.
2. Beg AA, Baltimore D. 1996. An essential role for Nf-κB in preventing TNF-α-induced cell death. Science 274:782-784.
3. Bond M, Fabunmi RP, Baker AH, Newby AC. 1998. Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NFκB. FEBS Lett 435:29-34.
4. Bours V, Franzoso G, Azarenko V, Park S, Kanno T, Brown K, Siebenlist U. 1993. The oncoprotein Bcl-3 directly transactivates through KB motifs via association with DNA-binding p50B homodimers. Cell 72:729-739.
5. Cai ZZ, Körner M, Tarantino N, Chouaib S. 1997. IκBα overexpression in human breast carcinoma MCF7 cells inhibits nuclear factor-κB activation but not tumor necrosis factors-α-induced apoptosis. J Biol Chem 272:96-101.
6. Chen E, Li CC. 1998. Association of cdk2/cyclin E and Nf-κB complexes at G1/S phase. Biochem Biophys Res Commun 249: 728-734.
7. Chen C, Edelstein LC, Gelinas C. 2000. The Rel/Nf-κB family directly activates expression of the apoptosis inhibitor Bcl-x(L). Mol Cell Biol 20:2687-2695.
8. Clarkson RWE, Heeley JL, Chapman R, Aillet F, Hay RT, Wyllie A, Watson CJ. 2000. Nf-κB inhibits apoptosis in murine mammary epithelia. J Biol Chem 275:12737-12742.
9. Cogswell PC, Guttridge DC, Funkhouser WK, Baldwin AS. 2000. Selective activation of NF-κB subunits in human breast cancer: potential roles for NF-κB2/p52 and for Bcl-3. Oncogene 19:1123-1131.
10. Cohen LA. 1982. Isolation and characterization of a serially cultivated, neoplastic, epithelial cell line from the N-nitrosomethylurea induced rat mammary adenocarcinoma. In Vitro 18:565-575.
11. Creasey AA, Doyle LV, Reynolds MT, Jung T, Lin LS, Vitt CR. 1987. Biological effects of recombinant human tumor necrosis factor and its novel muteins on tumor and normal cell lines. Cancer Res 47:145-149.
12. Darcy KM, Wohlhueter AL, Zangani D, Vaughan MM, Russell JA, Masso-Welch PA, Varela LM, Shoemaker SF, Horn E, Lee P-PH, Huang R-Y, Ip MM. 1999. Selective changes in EGF receptor expression and function during the proliferation, differentiation and apoptosis of mammary epithelial cells. Eur J Cell Biol 78:511-523.
13. Darcy KM, Black JD, Hahm HA, Ip MM. 1991. Mammary organoids from immature virgin rats undergo ductal and alveolar morphogenesis when grown within a reconstituted basement membrane. Exp Cell Res 196:49-65.
14. Darcy KM, Zangani D, Lee P-PH, Ip MM. 2000. Isolation and culture of normal rat mammary epithelial cells. In: Ip MM, Asch BB, editors. Methods in mammary gland biology and breast cancer research. New York: Kluwer Academic/Plenum Publishers, p 163-175.
15. Dejardin E, Bonizzi G, Bellahcene A, Castronovo V, Merville MP, Bours V. 1995. Highly-expressed p100/p52 (NFKB2) sequesters other Nf-κB-related proteins in the cytoplasm of human breast cancer cells. Oncogene 11:1835-1841.
16. Dollbaum C, Creasey AA, Dairkee SH, Hiller AJ, Rudolph AR, Lin L, Vitt C, Smith HS. 1988. Specificity of tumor necrosis factor toxicity for human mammary carcinomas relative to normal mammary epithelium and correlation with response to doxorubicin. Proc Natl Acad Sci USA 85:4740-4744.
17. Eggermont AMM, Manusama ER, Ten Hagen TLM. 1996. Regional application of TNFα in the treatment of cancer: a preclinical-clinical interactive program. J Inflamm 47:104-113.
18. Ehrke MJ, Ho RLX, Hori K. 1988. Species-specific TNF induction of thymocyte proliferation. Cancer Immunol Immunother 27:103-108.
19. Fujita T, Nolan GP, Liou HC, Scott ML, Baltimore D. 1993. The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-KB p50 homodimers. Genes Dev 7:1354-1363.
20. Hahm HA, Ip MM. 1990. Primary culture of normal rat mammary epithelial cells within a basement membrane matrix. I. Regulation of proliferation by hormones and growth factors. In Vitro Cell Dev Biol 26:791-802.
21. Hahm HA, Ip MM, Darcy K, Black JD, Shea WK, Forczek S, Yoshimura M, Oka T. 1990. Primary culture of normal rat mammary epithelial cells within a basement membrane matrix. II. Functional differentiation under serum-free conditions. In Vitro Cell Dev Biol 26:803-814.
22. Harant H, De Martin R, Andrew PJ, Foglar E, Dittrich C, Lindley IJD. 1996. Synergistic activation of interleukin-8 gene transcription by all-trans-retinoic acid and tumor necrosis factor-α involves the transcription factor Nf-κB. J Biol Chem 271:26954-26961.
23. Haslam SZ, Bern HA. 1977. Histopathogenesis of 7,12-dimethylben-z[a]anthracene-induced rat mammary tumors. Proc Natl Acad Sci USA 74:4020-4024.
24. Heissmeyer V, Krappmann D, Wulczyn FG, Scheidereit C. 1999. Nf-κB p105 is a target of IκB kinases and controls signal induction of Bcl-3-p50 complexes. EMBO J 18:4766-4778.
25. Ip MM, Shoemaker SF, Darcy KM. 1992. Regulation of rat mammary epithelial cell proliferation and differentiation by tumor necrosis factor alpha. Endocrinology 130:2833-2844.
26. Ip MM, Masso-Welch PA, Shoemaker SF, Shea-Eaton WK, Ip C. 1999. Conjugated linoleic acid inhibits proliferation and induces apoptosis of normal rat mammary epithelial cells in primary culture. Exp Cell Res 250:22-34.
27. Kim DW, Sovak MA, Zanieski G, Nonet G, Romieu-Mourez R, Lau AW, Hafer LJ, Yaswen P, Stampfer M, Rogers AE, Russo J, Sonenshein GE. 2000. Activation of Nf-κB/Rel occurs early during neoplastic transformation of mammary cells. Carcinogenesis 21:871-879.
28. Knight B, Yeoh GC, Husk KL, Ly T, Abraham LJ, Yu C, Rhim JA, Fausto N. 2000. Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice. J Exp Med 192:1809-1818.
29. Kolenko V, Bloom T, Rayman P, Bukowski R, Hsi E, Finke J. 1999. Inhibition of NF-κB activity in human T lymphocytes induces caspase-dependent apoptosis without detectable activation of caspase-1 and -3. J Immunol 163:590-598.
30. Kundu M, Guermah M, Roeder RG, Amini S, Khalili K. 1997. Interaction between cell cycle regulator, E2F-1, and Nf-κB mediates repression of HIV-1 gene transcription. J Biol Chem 272:29468-29474.
31. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head zof bacteriophage T4. Nature 227:680-685.
32. Lee P-PH, Hwang J-J, Murphy G, Ip MM. 2000. Functional significance of MMP-9 in TNF-induced proliferation and branching morphogenesis of mammary epithelial cells. Endocrinology 141: 3764-3773.
33. Lin R, Gewert D, Hiscott J. 1995a. Differential transcriptional activation in vitro by Nf-κB/Rel proteins. J Biol Chem 270:3123-3131.
34. Lin YZ, Yao S, Veach RA, Torgerson TR, Hawiger J. 1995b. Inhibition of nuclear translocation of transcription factor Nf-κB by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J Biol Chem 270:14255-14258.
35. Lin L, DeMartino GN, Greene WC. 1998. Cotranslational biogenesis of Nf-κB p50 by the 26S proteosome. Cell 92:819-828.
36. Luque I, Gelinas C. 1997. Rel/Nf-κB transcription factors and the control of apoptosis. Sem Cancer Biol 8:103-112.
37. Marr RA, Addison CL, Snider D, Muller WJ, Gauldie J, Graham FL. 1997. Tumour immunotherapy using an adenoviral vector expressing a membrane-bound mutant of murine TNFα. Gene Therapy 4:1181-1188.
38. May MJ, Ghosh S. 1997. Rel/Nf-κB and IkB proteins: an overview. Sem Cancer Biol 8:63-74.
39. Moore RJ, Owens DM, Stamp G, Arnott C, Burke F, East N, Holdsworth H, Turner L, Rollins B, Pasparakis M, Kollias G, Balkwill F. 1999. Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis. Nat Med 5:828-831.
40. Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet RJ Jr., Sledge GW. 1997. Constitutive activation of Nf-κB during progression of breast cancer to hormone-independent growth. Mol Cell Biol 17:3629-3639.
41. Olnes MJ, Kurl RN. 1994. Isolation of nuclear extracts from fragile cells: a simplified procedure applied to thymocytes. Biotechniques 17:828-829.
42. Palayoor ST, Youmell MY, Calderwood SK, Coleman CS, Price BD. 2000. Constitutive activation of IkB kinase a and Nf-κB in prostate cancer cells is inhibited by ibuprofen. Oncogene 18:7389-7394.
43. Russo J, Gusterson BA, Rogers AE, Russo IH, Wellings SR, Van S, Zwieten MJ. 1990. Comparative study of human and rat mammary tumorigenesis. Lab Invest 62:244-278.
44. Sha WC, Liou HC, Tuomanen EI, Baltimore D. 1995. Targeted disruption of the p50 subunit of Nf-κB leads to multifocal defects in immune responses. Cell 80:321-330.
45. Shea-Eaton WK, Lee P-PH, Ip MM. 2001. Regulation of milk protein gene expression in normal mammary epithelial cells by tumor necrosis factor. Endocrinology 142:2558-2568.
46. Singh S, Aggarwal BB. 1995. Protein-tyrosine phosphatase inhibitors block tumor necrosis factor-dependent activation of the nuclear transcription factor Nf-κB. J Biol Chem 270:10631-10639.
47. Sonenshein GE. 1997. Rel/NFκB transcription factors and the control of apoptosis. Sem Cancer Biol 8:113-120.
48. Sovak MA, Bellas RE, Kim DW, Zanieski GJ, Rogers AE, Traish AM, Sonenshein GE. 1997. Aberrant nuclear factor-κB/Rel expression and the pathogenesis of breast cancer. J Clin Invest 100:2952-2960.
49. Suganuma T, Okabe S, Marino MW, Sakai A, Sueoka E, Fujiki H. 1999. Essential role of tumor necrosis factor in tumor promotion as revealed by TNF-α-deficient mice. Cancer Res 59:4516-4518.
50. Sugarman BJ, Aggarwal BB, Hass PE, Figari IS, Palladino MA. 1985. Recombinant human tumor necrosis factor-α: effects on proliferation of normal and transformed cells in vitro. Science 230:943-945
51. Tamami M, Lindholm PF, Brady JN. 1996. The retinoblastoma gene product (Rb) induces binding of a conformationally inactive nuclear factor-κB. J Biol Chem 271:24551-24556.
52. Thompson HJ, Adlakha H. 1991. Dose-responsive induction of mammary gland carcinomas by the intraperitoneal injection of 1-methyl-1-nitrosourea. Cancer Res 51:3411-3415.
53. Thompson HJ, McGinley JN, Rothhammer K, Singh M. 1995. Rapid induction of mammary intraductal proliferations, ductal carcinoma in situ and carcinomas by the injection of sexually immature female rats with 1-methyl-1-nitrosourea. Carcinogenesis 16:2407-2411.
54. Thompson HJ, McGinley J, Rothhammer K, Singh M. 1998. Ovarian hormone dependence of pre-malignant and malignant mammary gland lesions induced in pre-pubertal rats by 1-methyl-1-nitro-sourea. Carcinogenesis 19:383-386.
55. Thompson HJ, Singh M, McGinley J. 2000. Classification of premalignant and malignant lesions developing in the rat mammary gland after injection of sexually immature rats with 1-methyl-1-nitrosourea. J Mammary Gland Biol Neoplasia 5:201-210.
56. Torgerson TR, Colosia AD, Donahue JP, Lin YZ, Hawiger J. 1998. Regulation of NF-κB, AP-1, NFAT, and STAT1 nuclear import in T lymphocytes by noninvasive delivery of peptide carrying the nuclear localization sequence of NF-κB p50. J Immunol 161:6084-6092.
57. Tsai SC, Miller BE, Jones RF, Heppner GH. 1997. Tumor necrosis factor α-induced stimulation of neoplastic progression of preneoplastic, hyperplastic alveolar nodule line C4. Int J Oncol 10:1209-1215.
58. Ueda H, Yamazaki M. 1997. Induction of tumor necrosis factor in a murine tumor by systemic administration of a novel synthetic lipid A analogue, ONO-4007. J Immunother 20:65-69.
59. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM. 1996. Suppression of TNF-α-induced apoptosis by NF-κB. Science 274: 787-789.
60. Varela LM, Ip MM. 1996. Tumor necrosis factor-α: a multifunctional regulator of mammary gland development. Endocrinology 137:4915-4924.
61. xVarela LM, Darcy KM, Ip MM. 1997. The epidermal growth factor receptor is not required for tumor necrosis factor-α action in normal mammary epithelial cells. Endocrinol 138:3891-3900.
62. Wang CY, Mayo MW, Baldwin AS. 1996. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 274:784-787.
63. Watanabe N, Iwamura T, Shinoda T, Fujita T. 1997. Regulation of NFKB1 proteins by the candidate oncoprotein BCL-3: generation of Nf-κB homodimers from the cytoplasmic pool of p50-p105 and nuclear translocation. EMBO J 16:3609-3620.
64. Wu H, Lozano G. 1994. Nf-κB activation of p53: a potential mechanism for suppressing cell growth in response to stress. J Biol Chem 269:20067-20074.